Our thanks to Anita

As our long-serving President completes her term of office, we thank her for all she has done for our Society.

ESPE President Anita Hokken-Koelega stepped down from her role in early September, at the end of her second and final term of office. An extraordinary leader, Anita’s tenure as President has been marked by her unwavering dedication, leadership, and a profound commitment to ESPE’s mission.

Anita’s journey with ESPE began 17 years ago. For 6 years, she served as ESPE Treasurer, where her financial expertise and meticulous attention to detail played a pivotal role in strengthening our financial foundation. Her contributions in this role were instrumental in ensuring the stability and growth of the Society.

During her 6 years as President, Anita has been a driving force behind numerous initiatives and achievements. One example was the creation of the Affiliate Society Group, which reaches paediatric endocrinologists across Europe. Another was her work on the ground-breaking EndoCompass initiative, which aims to create opportunities for the pioneers of endocrine science. Her strategic vision and ability to inspire those around her have led to significant advancements in our programmes and services. Under her leadership, we have attained new heights, expanded our reach, and made a lasting impact on the communities we serve.

Anita’s legacy is one of passion, perseverance and progress. Her leadership has not only guided us through challenges, but has also positioned us for a future filled with promise and potential. As we reflect on her time with ESPE, we are reminded of the countless ways in which she has shaped our organisation and the lives of those we serve.

Anita’s departure marks the end of an era, but her influence will continue to resonate within our Society for years to come. We extend our heartfelt thanks to Anita for her exceptional leadership and unwavering commitment. As she embarks on the next chapter of her journey, we wish her all the best and look forward to honouring her legacy in the future.